AURKA and Ewing sarcoma: This study identified a synergistic combination of inhibitors for KIF11 (SB-743921) and AURKA (VIC-1911) that demonstrated significant pre-clinical activity in vitro and efficacy in an in vivo xenograft mouse model of Ewing sarcoma.